# IntelliStent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy

> **NCT06072937** · NA · NOT_YET_RECRUITING · sponsor: **HeartPoint Global** · enrollment: 10 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension
- Dilated Cardiomyopathy
- Congenital Heart Disease

## Interventions

- **DEVICE:** IntelliStent

## Key facts

- **NCT ID:** NCT06072937
- **Lead sponsor:** HeartPoint Global
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-04
- **Primary completion:** 2025-06-04
- **Final completion:** 2026-06-04
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06072937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06072937, "IntelliStent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06072937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*